Journals / The Anatolian Journal of Cardiology / 2022 / Cilt: 26 - Sayı: 5

Enhanced External Counterpulsation Effects on Venous Leg Symptoms

Pages
401–406
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the total VEIN score did not change after the enhanced external counterpulsation procedure, improvement in swelling and night cramps underlines the beneficial effects of enhanced external counterpulsation through the venous vascular territory.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Venous diseases encompass a large spectrum of abnormalities in the venous system with complaints, such as aching and swelling.
📊
Key Findings & Data:Enhanced external counterpulsation, proven safe and effective in patients with coronary artery disease and chronic heart failure, is a technique that increases venous return and augments diastolic blood pressure.
💡
Conclusion & Impact:Although the total VEIN score did not change after the enhanced external counterpulsation procedure, improvement in swelling and night cramps underlines the beneficial effects of enhanced external counterpulsation through the venous vascular territory.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Venous diseases encompass a large spectrum of abnormalities in the venous system with complaints, such as aching and swelling. Enhanced external counterpulsation, proven safe and effective in patients with coronary artery disease and chronic heart failure, is a technique that increases venous return and augments diastolic blood pressure. This study assessed the effects of enhanced external counterpulsation on symptoms of venous disease using the Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms questionnaire. Methods: This study was designed prospectively for evaluating venous symptoms before and after enhanced external counterpulsation treatment. The study population consisted of 30 consecutive patients who were admitted to the cardiology clinic. The Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms questionnaire was applied to assess venous symptoms one day before and after enhanced external counterpulsation treatment. Results: The mean age of the patients was 64.62 ± 9.67 years. After 35 hours of enhanced external counterpulsation, 28 patients (93%) had at least 1 New York Heart Association functional class reduction compared with baseline and 43% of patients had 2 New York Heart Association functional classes improvement. The New York Heart Association class significantly decreased after enhanced external counterpulsation treatment (P< .001). There was a significant improvement in their swelling and night cramps symptoms compared with baseline (P< .001 and P = .05, respectively). Also, The left ventricular ejection fraction significantly increased after the enhanced external counterpulsation treatment (P = .02). Conclusions: The findings obtained in the present study suggested that patients treated with enhanced external counterpulsation showed a significant reduction in swelling and night cramps symptoms. Although the total VEIN score did not change after the enhanced external counterpulsation procedure, improvement in swelling and night cramps underlines the beneficial effects of enhanced external counterpulsation through the venous vascular territory.

🔖

Cite This Article

YETKİN, E., TURHAN, H., ÇUĞLAN, B. (2022). Enhanced External Counterpulsation Effects on Venous Leg Symptoms. The Anatolian Journal of Cardiology, Cilt: 26 - Sayı: 5, 401–406. https://ajindex.com/articles/597192

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Braith RW, Casey DP, Beck DT. Enhanced external counterpulsation for ischemic heart disease: a look behind the curtain. Exer Sport Sci Rev. 2012
  2. 40(3):145-152. [CrossRef] 2. Amin F, Al Hajeri A, Civelek B, Fedorowicz Z, Manzer BM. Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2010
  3. 2(2):CD007219. [CrossRef] 3. Soran O, Ikizler C, Sengül A, Çuğlan B, Kennard E, Kelsey S. Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. Turk Kardiyol Dern Ars. 2012
  4. 40(4):323-330. [CrossRef] 4. Soran O, Kennard ED, Bart BA, Kelsey SF, IEPR Investigators. Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. Congest Heart Fail. 2007
  5. 13(1):36-40. [CrossRef] 5. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999
  6. 33(7):1833-1840. [CrossRef] 6. Singh V, Kumari G, Chhajer B, Jhingan AK, Dahiya S. A comparative assessment to evaluate enhanced external counter pulsation effect on physical profile and quality of life in diabetic and non-diabetic coronary heart disease patients. J Appl Pharm Sci. 2018:113-123. 7. Yang DY, Wu GF. Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: beyond the hemodynamics. Int J Cardiol. 2013
  7. 166(1):38-43. [CrossRef] 8. Nicolaides AN, Labropoulos N. Burden and suffering in chronic venous disease. Adv Ther. 2019
  8. 36(Suppl 1):1-4. [CrossRef] 9. Wittens C, Davies AH, Bækgaard N, et al. Editor’s choice - management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015
  9. 49(6):678-737. [CrossRef] 10. Yetkin E, Ozturk S, Cuglan B, Turhan H. Symptoms in dilating venous disease. Curr Cardiol Rev. 2020
  10. 16(3):164-172. [CrossRef] 11. Yetkin E, Ileri M. Dilating venous disease. Pathophysiology and a systematic aspect to different vascular territories. Med Hypo. 2016
  11. [CrossRef] 12. Yetkin E, Ozturk S. Dilating vascular diseases: pathophysiology and clinical aspects. Int J Vasc Med. 2018
  12. 9024278. [CrossRef] 13. Padberg FT, Jr. CEAP classification for chronic venous disease. Dis Mon. 20